A young intern at the IPC carefully places a fresh copy of IP 2032 on a shelf. Behind it, barely visible, is the spine of the IP 2014 . Not archived. Not deleted. Kept. Just in case.
But the drug’s current monograph (IP 2028) doesn’t test for the dimer. The government insists the drug is safe. The manufacturer, now a global giant with political ties, threatens lawsuits. indian pharmacopoeia 2014
The chase takes them from the flooded slums of Mumbai (where Arjun collects blister packs from a dead man’s widow) to the sterile, locked lab at the IPC headquarters. Meera poses as a consultant to access the archive room. Arjun, using his old ID card that still opens a side door, sneaks into the now-defunct quality-control wing. A young intern at the IPC carefully places